Belinda Bartolo - Living Cell Chief Officer
| LVCLF Stock | USD 0.01 0 293.75% |
Insider
Belinda Bartolo is Chief Officer of Living Cell Technologies
| Phone | 61 3 8689 9997 |
| Web | https://www.lctglobal.com |
Living Cell Management Efficiency
The company has return on total asset (ROA) of (0.3084) % which means that it has lost $0.3084 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7233) %, meaning that it generated substantial loss on money invested by shareholders. Living Cell's management efficiency ratios could be used to measure how well Living Cell manages its routine affairs as well as how well it operates its assets and liabilities.Living Cell Technologies has accumulated 228.44 K in total debt with debt to equity ratio (D/E) of 0.1, which may suggest the company is not taking enough advantage from borrowing. Living Cell Technologies has a current ratio of 17.48, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Living Cell until it has trouble settling it off, either with new capital or with free cash flow. So, Living Cell's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Living Cell Technologies sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Living to invest in growth at high rates of return. When we think about Living Cell's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Christopher Moulton | Eastern Co | N/A | |
| Soohyung Kim | Ballys Corp | 46 | |
| Jennifer Davis | Procter Gamble | 52 | |
| Jim Ryan | Ballys Corp | N/A | |
| Nicklas Lentine | Eastern Co | N/A | |
| Thomas Finn | Procter Gamble | N/A | |
| Terrence Downey | Ballys Corp | 66 | |
| Jeffrey Rollins | Ballys Corp | 56 | |
| Julian Thurston | Unilever PLC ADR | N/A | |
| Ken Patel | Procter Gamble | N/A | |
| M Grabowski | Procter Gamble | 52 | |
| Loic Tassel | Procter Gamble | N/A | |
| Mindy Sherwood | Procter Gamble | N/A | |
| Jan Bijl | Unilever PLC ADR | 74 | |
| Wanda Wilson | Ballys Corp | 71 | |
| Reginaldo Ecclissato | Unilever PLC ADR | 52 | |
| Monica Turner | Procter Gamble | 58 | |
| Bradley Chhay | RCI Hospitality Holdings | 40 | |
| Fatima Francisco | Procter Gamble | 56 | |
| Christine McCarthy | Procter Gamble | 65 | |
| Sardar CFA | Biglari Holdings | 47 | |
Management Performance
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 |
Living Cell Technologies Leadership Team
Elected by the shareholders, the Living Cell's board of directors comprises two types of representatives: Living Cell inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Living. The board's role is to monitor Living Cell's management team and ensure that shareholders' interests are well served. Living Cell's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Living Cell's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Belinda Bartolo, Chief Officer | ||
| Bus FCIS, Company Sec | ||
| BSc BSc, Interim Officer | ||
| Daya Uka, Chief Officer |
Living Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Living Cell a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.72 | |||
| Return On Asset | -0.31 | |||
| Operating Margin | (428.70) % | |||
| Current Valuation | 12.53 M | |||
| Shares Outstanding | 1.29 B | |||
| Shares Owned By Insiders | 33.99 % | |||
| Price To Earning | (31.67) X | |||
| Price To Book | 6.96 X | |||
| Price To Sales | 5,587 X | |||
| Revenue | 3.4 K |
Currently Active Assets on Macroaxis
Other Information on Investing in Living Pink Sheet
Living Cell financial ratios help investors to determine whether Living Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Living with respect to the benefits of owning Living Cell security.